(Q37103527)

18 August 2017

What women with ovarian cancer think and know about genetic testing (English)

1 reference

18 August 2017

1 reference

Molly S Daniels

2

0 references

Shannon N. Westin

3

object named as

Shannon N Westin

1 reference

18 August 2017

10

Karen H Lu

1 reference

18 August 2017

Robin A Lacour

1

1 reference

18 August 2017

Larissa A Meyer

4

1 reference

18 August 2017

Catherine C Burke

5

1 reference

18 August 2017

Kimberly A Burns

6

1 reference

18 August 2017

Shiney Kurian

7

1 reference

18 August 2017

Nicki F Webb

8

1 reference

18 August 2017

Terri B Pustilnik

9

1 reference

18 August 2017

language of work or name

English

0 references

publication date

6 August 2008

1 reference

18 August 2017

1 reference

18 August 2017

111

1 reference

18 August 2017

1

1 reference

18 August 2017

132-136

1 reference

18 August 2017

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3746752

PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers?

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3746752

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3746752

Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3746752

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3746752

Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3746752

Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3746752

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3746752

The decision to test in women receiving genetic counseling for BRCA1 and BRCA2 mutations.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3746752

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3746752

Psychosocial factors associated with the public's willingness to pay for genetic testing for cancer risk: a structural equations model.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3746752

Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions☆

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3746752

Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition

4 December 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.016

The role of financial factors in acceptance of clinical BRCA genetic testing

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.016

Testing the construct validity of willingness to pay valuations using objective information about risk and health benefit

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.016

Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18684498

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2008.06.016

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

18684498

1 reference